Isabelle Luquet

3.1k total citations
45 papers, 636 citations indexed

About

Isabelle Luquet is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Isabelle Luquet has authored 45 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 15 papers in Public Health, Environmental and Occupational Health and 14 papers in Genetics. Recurrent topics in Isabelle Luquet's work include Acute Myeloid Leukemia Research (36 papers), Acute Lymphoblastic Leukemia research (15 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Isabelle Luquet is often cited by papers focused on Acute Myeloid Leukemia Research (36 papers), Acute Lymphoblastic Leukemia research (15 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Isabelle Luquet collaborates with scholars based in France, Belgium and United States. Isabelle Luquet's co-authors include Christian Récher, Sarah Bertoli, Éric Delabesse, Suzanne Tavitian, Françoise Huguet, Emilie Bérard, Audrey Sarry, Norbert Vey, Arnaud Pigneux and Marie C. Béné and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Isabelle Luquet

44 papers receiving 631 citations

Peers

Isabelle Luquet

HEMAT

PHEOH

GENET

ONCOL

Amer M. Zeidan United States

Yajamanam Badrinath India

O. Krieger Austria

Mohammad Azab United States

Giambattista Bertani Italy

Hyewon Lee South Korea

Tracy Murphy Canada

José González Spain

Cécile Bally France

Marc Schwartz United States

Amer M. Zeidan United States

Isabelle Luquet

493 ×1.0

HEMAT

378 ×1.9

95 ×0.6

PHEOH

126 ×0.8

GENET

160 ×1.8

ONCOL

Citations per year, relative to Isabelle Luquet Isabelle Luquet (= 1×) peers Amer M. Zeidan

Countries citing papers authored by Isabelle Luquet

Since Specialization

Citations

This map shows the geographic impact of Isabelle Luquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Luquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Luquet more than expected).

Fields of papers citing papers by Isabelle Luquet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Luquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Luquet. The network helps show where Isabelle Luquet may publish in the future.

Co-authorship network of co-authors of Isabelle Luquet

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Luquet. A scholar is included among the top collaborators of Isabelle Luquet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Luquet. Isabelle Luquet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leroy, Harmony, Emilie Bérard, Isabelle Luquet, et al.. (2024). Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy. Cancer Medicine. 13(3). e7003–e7003. 1 indexed citations

Bie, Jolien De, Wendy Cuccuini, Christine Lefebvre, et al.. (2023). Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH). Current Research in Translational Medicine. 71(4). 103434–103434. 2 indexed citations

Mouchel, Pierre‐Luc, Emilie Bérard, Suzanne Tavitian, et al.. (2023). Vitamin C and D supplementation in acute myeloid leukemia. Blood Advances. 7(22). 6886–6897. 10 indexed citations

Largeaud, Laëtitia, Naïs Prade, Isabelle Luquet, et al.. (2023). Stem cell–like reprogramming is required for leukemia-initiating activity in B-ALL. The Journal of Experimental Medicine. 221(1). 2 indexed citations

Bie, Jolien De, Christine Lefebvre, Isabelle Luquet, et al.. (2023). Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH). Current Research in Translational Medicine. 71(4). 103431–103431. 3 indexed citations

Bertoli, Sarah, Laëtitia Largeaud, Jean‐Baptiste Rieu, et al.. (2022). Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia. Clinical Cancer Research. 29(1). 134–142. 11 indexed citations

Nguyen‐Khac, Florence, Audrey Bidet, Agnès Daudignon, et al.. (2022). The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH). Leukemia. 36(6). 1451–1466. 17 indexed citations

Tavitian, Suzanne, Sarah Bertoli, Françoise Huguet, et al.. (2020). Dactinomycin in acute myeloid leukemia with NPM1 mutations. European Journal Of Haematology. 105(3). 302–307. 9 indexed citations

Vergez, François, Marie-Laure Nicolau-Travers, Sarah Bertoli, et al.. (2020). CD34+CD38−CD123+ Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents. Cancers. 12(5). 1174–1174. 11 indexed citations

10.

Dumas, Pierre‐Yves, Sarah Bertoli, Emilie Bérard, et al.. (2020). Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study. Cancers. 12(8). 2044–2044. 5 indexed citations

11.

Bellière, Julie, Magali Colombat, Christian Récher, et al.. (2020). Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL–Negative Myeloproliferative Neoplasms. Kidney International Reports. 6(3). 737–745. 10 indexed citations

12.

Largeaud, Laëtitia, Emilie Bérard, Sarah Bertoli, et al.. (2019). Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors. Leukemia Research. 81. 82–87. 6 indexed citations

13.

Bertoli, Sarah, Suzanne Tavitian, Anne Huynh, et al.. (2017). Improved outcome for AML patients over the years 2000–2014. Blood Cancer Journal. 7(12). 635–635. 50 indexed citations

14.

Comont, Thibault, Suzanne Tavitian, Laurent Bardiaux, et al.. (2017). Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy. Leukemia Research. 61. 62–67. 29 indexed citations

15.

Nguyen‐Khac, Florence, Agnès Daudignon, Virginie Éclache, et al.. (2016). Cytogenetics in the management of hematologic malignancies: an update by the Groupe francophone de cytogénétique hématologique (GFCH). Annales de biologie clinique. 74(5). 509–510. 1 indexed citations

16.

Blanchet, Odile, Pascale Cornillet‐Lefèbvre, Laurence Baranger, et al.. (2012). Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples. BMC Medical Genomics. 5(1). 6–6. 4 indexed citations

17.

Chevallier, Patrice, Myriam Labopin, Pascal Turlure, et al.. (2011). A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study. Leukemia. 25(6). 939–944. 91 indexed citations

18.

Mullier, François, Sylvie Daliphard, Richard Garand, et al.. (2011). Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study. Annals of Hematology. 91(2). 203–213. 10 indexed citations

19.

Pigneux, Arnaud, Jean‐Luc Harousseau, Francis Witz, et al.. (2010). Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS. Journal of Clinical Oncology. 28(18). 3028–3034. 26 indexed citations

20.

Perrot, Aurore, Isabelle Luquet, Arnaud Pigneux, et al.. (2009). Prognostic Value of the ‘Monosomal Karyotype’ Entity in Elderly Patients with AML: a GOELAMS Study of 186 Patients with Unfavourable Cytogenetic Abnormalities.. Blood. 114(22). 1577–1577. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact